Insurance coverage for continuous glucose monitors (CGMs) during gestational diabetes is possible but not guaranteed. Most insurers tie CGM approval to insulin use, which means if you’re managing gestational diabetes with diet and exercise alone, you’ll likely face a denial. The specifics depend on whether you have private insurance, Medicare, or Medicaid, and even which state you live in.
The Insulin Requirement Most Insurers Share
The single biggest factor determining whether your insurance will cover a CGM is whether you take insulin. Medicare, for example, covers CGMs and related supplies (sensors, transmitters) for people with gestational diabetes, but only if a doctor confirms you take insulin or have a history of low blood sugar episodes. You also need a prescription for glucose testing supplies and training on how to use the device.
Major private insurers follow a similar pattern. UnitedHealthcare considers CGM “medically necessary” for people on intensive insulin therapy, defined as at least three insulin injections per day or use of an insulin pump. Anthem and Aetna apply comparable restrictions. The common thread: if your gestational diabetes is controlled without insulin, most plans won’t approve a CGM. That’s a significant gap, since many women with gestational diabetes manage their blood sugar through dietary changes and never progress to insulin.
Medicaid Coverage Varies by State
Medicaid programs set their own rules for CGM coverage, and a handful of states have started expanding access for gestational diabetes specifically. Colorado passed legislation (Senate Bill 24-168) that covers CGMs for pregnant individuals with gestational diabetes even if they’re not on insulin. That coverage lasts for the duration of the pregnancy.
Most state Medicaid programs haven’t gone this far. If you’re on Medicaid, check your state’s preferred diabetic supply list or call your plan directly. Coverage rules can change quickly as more states evaluate the cost-effectiveness of CGMs in pregnancy.
Prior Authorization Is Almost Always Required
Even when your insurance plan does cover CGMs, you typically can’t just pick one up at the pharmacy. Most plans require prior authorization, meaning your provider submits clinical documentation proving you meet the plan’s criteria. This usually includes your diabetes diagnosis, your current treatment regimen (specifically insulin use), and evidence that you’ve been trained on the device. Johns Hopkins Health Plans, as one example, requires clinical documentation for all CGM prior authorization requests submitted electronically or by fax.
The process can take days to weeks, which matters when gestational diabetes is a time-limited condition. If your provider anticipates you’ll need a CGM, ask them to start the authorization process early. Having glucose logs and a clear treatment plan documented in your medical record strengthens the case.
Why Providers Push for CGM Coverage
The clinical case for CGMs in gestational diabetes is strong and growing. Compared to traditional fingerstick monitoring, CGMs do a better job of keeping blood sugar in the target range and reducing the variability that can harm both mother and baby. A systematic review in the Journal of Diabetes Science and Technology found that CGM use was associated with lower rates of large-for-gestational-age babies, preterm birth, and NICU admissions.
One study found that the rate of fetal macrosomia (an abnormally large baby at birth) dropped from 20% with fingerstick monitoring to just 4% with a flash glucose monitoring system. Another showed that CGMs caught overnight high blood sugar in 47% of participants, compared to only 18% using fingersticks. Those missed spikes matter: women whose blood sugar stayed above target for 10% or more of their readings had dramatically higher rates of oversized babies (33% vs. 1.3%) and newborns needing IV glucose for low blood sugar (40% vs. 9%).
CGMs also helped with weight management during pregnancy. One study found that women using CGMs had significantly less excessive weight gain (33% vs. 56%), particularly when they started using the device early in their diagnosis. These outcomes are part of why advocacy groups argue that restricting CGM access to insulin users is both harmful and costly, since preventing complications like NICU stays saves far more than the device itself.
What a CGM Costs Without Insurance
If your insurance denies coverage or you’d rather not wait for authorization, paying out of pocket is an option, though not a cheap one. Dexcom offers a pharmacy savings program that takes over 50% off the standard cash price, with discounts of $210 per monthly sensor pack. A 60-day supply saves $400, and a 90-day supply saves $600. Even with those discounts, you’re looking at a meaningful monthly expense for a condition that may last several months.
Abbott’s FreeStyle Libre system tends to cost less at retail than Dexcom, and both manufacturers rotate promotional offers like free trial programs and discounted starter kits. The Association of Diabetes Care & Education Specialists maintains a searchable tool that matches patients with financial assistance programs by product, brand, and insurance type. It’s worth checking before you assume you’re stuck with full price.
Steps to Improve Your Chances of Approval
If you’re on insulin for gestational diabetes, your path to coverage is relatively straightforward. Make sure your provider documents your insulin regimen, prescribes the CGM, and submits for prior authorization with supporting records. Ask whether the CGM will be billed as durable medical equipment or through the pharmacy benefit, since some plans cover it through one channel but not the other.
If you’re not on insulin, your options are narrower but not nonexistent. Check whether your state has expanded Medicaid coverage for gestational diabetes CGMs. Ask your provider to submit a prior authorization request anyway, with documentation of why CGM monitoring is medically necessary in your specific case, such as difficulty maintaining target glucose levels, a history of large babies, or glucose variability that fingersticks aren’t catching. Some plans allow appeals, and a well-documented case occasionally succeeds even when the standard criteria aren’t met.
If all else fails, ask about manufacturer savings programs and free trials. A gestational diabetes diagnosis typically lasts only a few months, so even a short promotional offer can cover a meaningful portion of the time you need the device.